NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE116919 Query DataSets for GSE116919
Status Public on Jul 09, 2019
Title Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Summary This SuperSeries is composed of the SubSeries listed below.
 
Overall design Refer to individual Series
 
Citation(s) 31000582
Submission date Jul 11, 2018
Last update date Oct 08, 2019
Contact name Bradley E Bernstein
E-mail(s) Bradley_bernstein@dfci.harvard.edu
Organization name Dana Farber Cancer Institute
Department Cancer Biology
Lab Bradley Bernstein
Street address 450 Brookline Ave
City Boston
State/province Massachusetts
ZIP/Postal code 02215
Country USA
 
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
Samples (48)
GSM3263316 MDAMB231_BRD2_DMSO_48h
GSM3263317 MDAMB231_BRD2_10uMGSK2801_48h
GSM3263318 MDAMB231_BRD2_100nMJQ1_48h
This SuperSeries is composed of the following SubSeries:
GSE116879 Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (ChIPseq)
GSE116907 Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq)
Relations
BioProject PRJNA480608

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE116919_RAW.tar 44.8 Mb (http)(custom) TAR (of BED, NARROWPEAK, TXT)
SRA Run SelectorHelp

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap